Elrose Labs Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Elrose Labs General Information


Developer of a medical product designed to treat Molluscum disease. The company's product is based in a blend of phytochemical and antiviral compounds found in nature which helps to remove lesions and pain from the disease easily, enabling users to get relief from this disease within one to two weeks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • 3875 St Johns Parkway
  • Sanford, FL 32771
  • United States
+1 (855) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elrose Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Elrose Labs’s complete valuation and funding history, request access »

Elrose Labs Executive Team (3)

Name Title Board Seat Contact Info
James Ragsdale Chief Executive Officer
Sass Robert President
Paul Konz Chief Operating Officer
To view Elrose Labs’s complete executive team members history, request access »

Elrose Labs Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University of Central Florida Business Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Elrose Labs’s complete investors history, request access »